PWE-126 Survival and Recurrent Disease in Patients With Resected Primary Small Bowel Neuroendocrine Tumours

Gut - United Kingdom
doi 10.1136/gutjnl-2012-302514d.126
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

OC-049 Rectal Neuroendocrine Tumours: Management and Survival in 60 Patients

Gut
Gastroenterology
2014English

Increased Autophagy/Mitophagy Levels in Primary Tumours of Patients With Pancreatic Neuroendocrine Neoplasms

Endocrine
2020English

PWE-108 Factors Influencing the Management of Inflammatory Bowel Disease in Primary Care

Gut
Gastroenterology
2014English

PWE-158 Thymosin Beta 4 as a Putative Marker in Neuroendocrine Tumours

Gut
Gastroenterology
2013English

PWE-262 Patients in England With Inflammatory Bowel Disease (IBD) Who Develop Colorectal Cancer (CRC) Have Shortened Survival When Compared With Patients With Sporadic CRC

Gut
Gastroenterology
2015English

PWE-258 Thiopurine Monitoring in Inflammatory Bowel Disease Patients at a District General Hospital

Gut
Gastroenterology
2012English

Carcinoid Heart Disease and Recurrent Hypertensive Crises in a Patient With Primary High-Grade Ovarian Neuroendocrine Carcinoma

Journal of Integrative Cardiology
2016English

Circulating Immune Cells in Patients With Surgically Resected Nonfunctional Pancreatic Neuroendocrine Tumors

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Circulating Tumour Cells and Their Association With Bone Metastases in Patients With Neuroendocrine Tumours

British Journal of Cancer
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy